220
U. Do¨rfler et al. / Journal of Organometallic Chemistry 614–615 (2000) 215–222
mg, 0.5 mmol) was added. The solution was stirred for
30 min at r.t., cooled to −78°C, and then MeI (72 mg,
0.55 mmol) was added. After stirring a further 1 h the
more volatile components were removed in vacuo, the
solid residue redissolved in CH2Cl2 and the products
separated and purified by repeated preparative TLC.
Development with hexane–CH2Cl2 (3:7) gave [(Et-
MeHN)B8H11NHEt] (5) (24 mg, 0.12 mmol, 37%, RF:
0.7) and [(EtH2N)B8H11NHEt] (1) (25 mg, 0.134 mmol,
42%, RF 0.4); MS (EI, 70 eV, 200°C) for compound (5):
m/z=200 [M+, 12%].
3.7. Synthesis of [(Et2HN)B8H11NHMe] (9)
A sample of compound (1) (50 mg, 0.31 mmol) was
dissolved in benzene (10 ml), and NHEt2 (65 ml, 0.62
mmol) was added. After 3 h at reflux temperature the
more volatile components were removed in vacuo, the
solid residue redissolved in CH2Cl2 and the products
separated and purified by repeated preparative TLC.
Development in CH2Cl2 gave [(Et2HN)B8H11NHMe]
(9) (38 mg, 0.19 mmol, 61%, RF 0.53) and
[BH3(NHEt2)] (5 mg, 0.006 mmol, 19%, RF 0.49); MS
(EI, 70 eV, 200°C) for compound (9): m/z=200 [M+,
34%].
3.4. Synthesis of (EtMe2N)B8H11NHEt] (6)
NaH (20 mg, 0.83 mmol) was added to a solution of
compound 1 (60 mg, 0.32 mmol) in THF (5 ml) at r.t.
The mixture was stirred for 30 min, and then MeI (119
mg, 0.83 mmol) was added. After stirring for 1 h the
more volatile components were removed in vacuo, the
solid residue redissolved in CH2Cl2 and the products
separated and purified by repeated preparative TLC.
3.8. Synthesis of [(C5H5N)B8H11NHEt] (10)
Pyridine (22 ml, 0.268 mmol) was added to a solution
of compound (1) (25 mg, 0.134 mmol) in benzene (10
ml), and the solution was then heated at reflux for 3 h.
The more volatile components were removed in vacuo,
the solid residue redissolved in CH2Cl2 and the prod-
ucts separated and purified by repeated preparative
TLC. Development in CH2Cl2 gave [(C5H5N)B8H11-
NHMe] (10) (38 mg, 0.08 mmol, 61%, RF 0.74) and
[BH3(NC5H5)] (2 mg, 0.02 mmol, 16%, RF 0.57); MS
(EI, 70 eV, 200°C) for compound (10): m/z=221
[M+, 22%], 217 [M+−3H, 30%].
Development
in
hexane–CH2Cl2
(3:7)
gave
[(EtMe2N)B8H11NHEt] (6) (31 mg, 0.144 mmol, 45%,
RF 0.82) and [(EtH2N)B8H11NHEt] (1) (13 mg, 0.7
mmol, 22%, RF 0.4); MS (EI, 70 eV, 200°C) for com-
pound (6): m/z=214 [M+, 20%], 73 [NEtMe+2 , 45%].
3.5. Synthesis of (EtMe2N)B8H11NMeEt] (7)
A sample of compound (1) (40 mg, 0.22 mmol) was
dissolved in THF (5 ml), and NaH (18 mg, 0.75 mmol)
was added. The solution was stirred for 30 min at r.t.,
and MeI (107 mg, 0.75 mmol) was added. After stir-
rings for a further 2 h, the more volatile components
were removed in vacuo, the solid residue redissolved in
CH2Cl2, and the products separated and purified by
repeated preparative TLC. Development in hexane–
CH2Cl2 (3:7) gave [(EtMe2N)B8H11NMeEt] (7) (28 mg,
0.12 mmol, 57%, RF 0.9) and [(EtH2N)B8H11NHEt] (1)
(4 mg, 0.18 mmol, 9%, RF 0.4); MS (EI, 70 eV, 200°C)
for compound (7): m/z=228 [M+, 11%].
3.9. Synthesis of [(Ph3P)B8H11NHEt] (11)
Route (a): PPh3 (140 mg, 0.53 mmol) was added to a
solution of [(EtH2N)B8H11NHEt] (1) (100 mg, 0.53
mmol) in toluene (10 ml). The solution was then heated
at reflux for 14 h. Examination of the product mixture
by integrated NMR spectroscopy revealed a ca. 40:60
mol% mixture of [(Ph3P)B8H11NHEt] (11) and
[(EtH2N)B8H11NHEt] (1). Route (b): [RhCl(PPh3)3]
(100 mg, 0.25 mmol) was added to a solution of com-
pound (1) (20 mg, 0.108 mmol) in toluene (10 ml), and
the mixture then was heated at reflux for 2 h. The more
volatile components were removed in vacuo, the solid
residue redissolved in CH2Cl2 and the products sepa-
rated and purified by repeated preparative TLC. Devel-
3.6. Synthesis of (Et2HN)B8H11NHEt] (8)
NHEt2 (56 ml, 0.54 mmol) was added to a solution of
compound (1) (50 mg, 0.27 mmol) in benzene (10 ml).
After heating at reflux for 8 h, the more volatile compo-
nents were removed in vacuo, the solid residue redis-
solved in CH2Cl2 and the products separated and
purified by repeated preparative TLC. Development
with CH2Cl2 gave [(Et2HN)B8H11NHEt] (8) (18 mg,
0.084 mmol, 31%, RF 0.50) and [(EtH2N)B8H11NHEt]
(1) (26 mg, 0.14 mmol, 52%, RF 0.3); MS (EI, 70 eV,
200°C) for compound (8): m/z=214 [M+, 28%], 199
[M+−Me, 5%].
opment
with
hexane–CH2Cl2
(3:7)
gave
[(Ph3P)B8H11NHEt] (11) (26 mg, 0.064 mmol, 60%, RF
0.55); MS (EI, 70 eV, 200°C) for compound (11):
m/z=392 [M+, 11%], 262 [PPh+3 , 22%].
3.10. Synthesis of [(PhMe2P)B8H11NHEt] (12)
[PtCl2(PMe2Ph)2] (30 mg, 0.05 mmol) was added to a
solution of compound 1 (10 mg, 0.053 mmol) in toluene
(10 ml) and the solution then was heated at reflux for 2